You searched for viral vector - Page 14 of 53

Best in Biotech 25 Jun 2024

Spotlight on Georgia’s biotech industry: Seven companies to know about in 2024

…that prevents viruses from attaching to cells and also inhibits viral replication. The viral capsid is the protein shell that encases and protects the genetic material of a virus. By…

June 25, 2024 - 7 minutesmins - By Jules Adam

News and Trends 16 Nov 2022

Ascletis’ monkeypox tablet receives IND approval from the FDA

…antiviral activities including potent activities against both monkeypox and SARS-CoV-2 viruses. Ascletis has filed multiple patent applications globally for ASC10 and its use in viral diseases including monkeypox virus infection….

November 16, 2022 - 3 minutesmins - By Liza Laws

Roche announces Xofluza approval and new Elecsys IGRA SARS-CoV-2 test

News and Trends 15 Aug 2022

Roche announces influenza drug approval and new COVID test

…was the first new antiviral to be approved by the FDA in 20 years, and is the first innovation in mechanism of action for an influenza antiviral approved by the…

August 15, 2022 - 6 minutesmins - By Jim Cornall

hiv treatment immunologik christian setz 1

Interview 22 Feb 2018

Could a New Approach Help Us to Overcome Resistance to HIV Treatment?

…year, and stop their progression towards acquired immune deficiency syndrome (AIDS). Unlike anti-retroviral drugs, which target viral proteins, Immunologik’s candidate, IML-106, “attacks specific cellular proteins that are crucial for the…

February 22, 2018 - 4 minutesmins - By Alex Dale

gene therapy blood disorder hemophilia b

News and Trends 4 Feb 2021

HIV Drug Approvals Lift Hopes Amid Missed UN Targets

…of two antiretroviral drugs called cabotegravir and rilpirivine. Rilpirivine is traditionally taken daily as a pill to stop the HIV virus from replicating itself. The GlaxoSmithKline-owned company has repackaged it…

February 4, 2021 - 6 minutesmins - By Anita Chakraverty

In Depth 3 Apr 2024

Hepatitis B: are we edging closer to a cure?

…with chronic hepatitis B includes antiviral treatment with nucleoside/nucleotide analogs (NUCs). “Direct-acting antivirals that target the viral polymerase, which replicates the genome, are the most common treatment options for chronic…

April 3, 2024 - 9 minutesmins - By Willow Shah-Neville

News and Trends 23 Jul 2019

HIV Drug Suppresses Virus for Almost Two Years When Other Treatments Fail

A first-in-class HIV treatment developed by the UK company ViiV Healthcare has suppressed the virus in people who have become resistant to other antiretroviral drugs, providing protection for at least…

July 23, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 22 Nov 2019

ViiV Healthcare Licenses Long-Acting Antibody to Attack Hidden HIV

…longer than current antiretroviral therapies. The antibody is currently in an ongoing phase I trial run by the National Institute of Allergy and Infectious Diseases, part of the National Institutes…

November 22, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 25 Jul 2018

Two Drugs as Good as Three for Treating HIV

…blocks the step before integration where the viral RNA is transcribed into DNA. “We looked at patients that were new to therapy, so they’ll have higher viral loads. It’s…

July 25, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 31 Oct 2018

Forget Daily Pills: HIV Could Be Treated With Monthly Injections

…or every two months. After 40 months, 90% of the patients receiving monthly injections were virally suppressed and had little viral RNA circulating in their blood. Furthermore, 83% of patients…

October 31, 2018 - 2 minutesmins - By Jonathan Smith

In Depth 25 Jul 2017

Trouble in Paradise: How Biotech is Fighting Tropical Diseases

…was originally developed by the Institut from a traditional measles vaccine as a vector for large recombinant genes for antigens. The vector targets macrophages and dendritic cells, the most effective…

July 25, 2017 - 6 minutesmins - By Evelyn Warner

In Depth 25 Dec 2024

When biotech makes Christmas miracles a reality

…Opal received, both treatments utilize AAV vectors to deliver functional genes to retinal cells. AAV vectors are engineered to be non-pathogenic and can efficiently target retinal cells with minimal immune…

December 25, 2024 - 8 minutesmins - By Jules Adam

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: viral vector

Spotlight on Georgia’s biotech industry: Seven companies to know about in 2024

Ascletis’ monkeypox tablet receives IND approval from the FDA

Roche announces influenza drug approval and new COVID test

Could a New Approach Help Us to Overcome Resistance to HIV Treatment?

HIV Drug Approvals Lift Hopes Amid Missed UN Targets

Hepatitis B: are we edging closer to a cure?

HIV Drug Suppresses Virus for Almost Two Years When Other Treatments Fail

ViiV Healthcare Licenses Long-Acting Antibody to Attack Hidden HIV

Two Drugs as Good as Three for Treating HIV

Forget Daily Pills: HIV Could Be Treated With Monthly Injections

Trouble in Paradise: How Biotech is Fighting Tropical Diseases

When biotech makes Christmas miracles a reality

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!